JSSH
AZN icon

J. Safra Sarasin Holding’s AstraZeneca AZN Stock Holding History

J. Safra Sarasin Holding’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.9M Buy
169,998
+1,246
+0.7% +$234K 0.46% 60
2026
Q1 		$32.7M Buy
168,752
+167,614
+14,729% +$32.3M 0.56% 52
2025
Q4 		$210K Buy
+1,138
New +$200K ﹤0.01% 493

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

J. Safra Sarasin Holding's AZN Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its AstraZeneca (AZN) stake by 0.74% in Q2 2026, buying an estimated $234K and bringing the position to 169,998 shares worth $31.9M. The position accounts for 0.46% of the portfolio, ranked #60.

J. Safra Sarasin Holding first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $32.7M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • J. Safra Sarasin Holding held 169,998 shares of AstraZeneca worth $31.9M as of Q2 2026.
  • J. Safra Sarasin Holding bought 1,246 AstraZeneca shares in Q2 2026, an estimated $234K.
  • AstraZeneca made up 0.46% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #60 holding.
  • J. Safra Sarasin Holding first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • J. Safra Sarasin Holding's AstraZeneca position peaked at $32.7M in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.